Obesity Trial, Recruiting NCT06826963 Sponsor: Universita di Verona Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06826963
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 65 and 85 years old
  • People who have been diagnosed with stable heart failure where the heart is either pumping normally (preserved function) or pumping with reduced strength (confirm with trial site for specific measurements)
  • People whose heart failure symptoms are classified as mild to moderate — meaning everyday activities cause little to some limitation (known as NYHA Class 1, 2, or 3)
  • People who have been diagnosed with sarcopenia (a condition involving low muscle strength and reduced muscle mass) or sarcopenic obesity (low muscle mass combined with excess body fat), based on specific measurements of muscle strength, muscle mass, and in some cases waist size — a trial site assessment would determine whether the specific measurements meet the criteria

Who may not be able to join:

  • People with severe obstructive heart disease
  • People with aortic valve stenosis (a narrowing of a major heart valve)
  • People who showed severe irregular heart rhythms during an initial exercise stress test
  • People who have a blood clot inside a heart chamber
  • People with severely high blood pressure in the lungs (above a specific measurement)
  • People who have had a blood clot in a vein or lung within the past three months
  • People who have previously had a heart transplant
  • People with other medical conditions that significantly limit their physical ability beyond what is caused by their heart failure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universita di Verona
Registry
ClinicalTrials.gov
Start date
15 October 2024
Est. completion
30 September 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Recruitment and Retention Rate; Session Attendance; Adherence to Training Volume; Program Tolerance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov